DK121861B - Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat. - Google Patents

Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat.

Info

Publication number
DK121861B
DK121861B DK581363AA DK581363A DK121861B DK 121861 B DK121861 B DK 121861B DK 581363A A DK581363A A DK 581363AA DK 581363 A DK581363 A DK 581363A DK 121861 B DK121861 B DK 121861B
Authority
DK
Denmark
Prior art keywords
thienylacetamidoceph
ylmethyl
pyridinium
carboxylate
preparation
Prior art date
Application number
DK581363AA
Other languages
Danish (da)
English (en)
Inventor
V Arkley
S Eardley
A Long
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK121861B publication Critical patent/DK121861B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B60VEHICLES IN GENERAL
    • B60GVEHICLE SUSPENSION ARRANGEMENTS
    • B60G11/00Resilient suspensions characterised by arrangement, location or kind of springs
    • B60G11/18Resilient suspensions characterised by arrangement, location or kind of springs having torsion-bar springs only

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DK581363AA 1962-12-14 1963-12-13 Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat. DK121861B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47316/62A GB1028563A (en) 1962-12-14 1962-12-14 Antibacterial derivative of 7-aminocephalosporanic acid

Publications (1)

Publication Number Publication Date
DK121861B true DK121861B (da) 1971-12-13

Family

ID=10444515

Family Applications (3)

Application Number Title Priority Date Filing Date
DK581363AA DK121861B (da) 1962-12-14 1963-12-13 Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat.
DK01907/71A DK125138B (cs) 1962-12-14 1971-04-21
DK190771AA DK125138C (da) 1962-12-14 1971-04-21 Analogifremgangsmåde til fremstilling af cephalosporinforbindelser.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK01907/71A DK125138B (cs) 1962-12-14 1971-04-21
DK190771AA DK125138C (da) 1962-12-14 1971-04-21 Analogifremgangsmåde til fremstilling af cephalosporinforbindelser.

Country Status (11)

Country Link
AT (1) AT249861B (cs)
BR (1) BR6355431D0 (cs)
CH (2) CH469023A (cs)
CS (2) CS158177B2 (cs)
CY (1) CY415A (cs)
DE (1) DE1445828A1 (cs)
DK (3) DK121861B (cs)
GB (1) GB1028563A (cs)
MY (1) MY6800009A (cs)
NL (1) NL7304127A (cs)
SE (2) SE320073B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins
US3536705A (en) * 1968-03-11 1970-10-27 Lilly Co Eli Delta**2-cephalosporin ester intermediate
IT1145686B (it) * 1979-05-25 1986-11-05 Glaxo Group Ltd Intermedi per la preparazione di antibiotici cefalosporinici e procedimento per prepararli
CN107793433A (zh) * 2017-11-15 2018-03-13 中国医药集团总公司四川抗菌素工业研究所 一种头孢噻啶的制备方法

Also Published As

Publication number Publication date
GB1028563A (en) 1966-05-04
DE1795600B2 (de) 1975-09-25
DK125138B (cs) 1973-01-02
CY415A (en) 1967-11-14
CS154598B2 (cs) 1974-04-30
DE1445828A1 (de) 1969-04-17
CS158177B2 (cs) 1974-10-15
DK125138C (da) 1973-07-02
BR6355431D0 (pt) 1973-09-20
CH442310A (de) 1967-08-31
SE350509B (cs) 1972-10-30
DE1795600A1 (de) 1972-01-27
MY6800009A (en) 1968-12-31
SE320073B (cs) 1970-02-02
NL7304127A (cs) 1973-06-25
AT249861B (de) 1966-10-10
CH469023A (de) 1969-02-28

Similar Documents

Publication Publication Date Title
DK118655B (da) Analogifremgangsmåde til fremstilling af p-aminoalkoxyphenylalkenderivater.
DK111920B (da) Fremgangsmåde til fremstilling af polyimider.
DK104675C (da) Fremgangsmåde til fremstilling af 3-hydroxy-N-nitro-picolinamid.
DK108570C (da) Fremgangsmåde til fremstilling af N-substituerede phenylsulfonyl-N'-cyclo-alkylurinstoffer.
DK115325B (da) Fremgangsmåde til fremstilling af fenylalkylsulfamider.
DK121861B (da) Analogifremgangsmåde til fremstilling af N-(7-2'-tienylacetamidoceph-3-em-3-ylmetyl)-pyridinium-4-karboxylat.
DK111447B (da) Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on.
DK103476C (da) Fremgangsmåde til fremstilling af 2-oxa-3-oxo-steroider.
DK124261B (da) Analogifremgangsmåde til fremstilling af tertiære carbamyltriazoler.
DK104414C (da) Fremgangsmåde til fremstilling af bis-N-acetylhydrazino-N'-karbonyl-metyl)-disulfid.
DK103512C (da) Fremgangsmåde til fremstilling af 3-nitroso-2-oxazolidon.
DK108915C (da) Fremgangsmåde til fremstilling af 21-acyloxy-acetyloxy-corticosteroider.
DK109329C (da) Fremgangsmåde til fremstilling af Δ<4>-6α-alkyl-19-nor-pregnener.
DK113499B (da) Fremgangsmåde til fremstilling af hjertervirksomme 4'-monoestere af cymarol.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK104065C (da) Fremgangsmåde til fremstilling af 3-phenylgranaten-(2)-derivater.
DK104063C (da) Fremgangsmåde til fremstilling af 4-hydroxy-5-halogenpyrimidiner.
DK115620B (da) Fremgangsmåde til fremstilling af 17α-klorætynyl-17βalkoksysteroider.
DK113647B (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-5-metoxypyrimidin.
DK115630B (da) Fremgangsmåde til fremstilling af 2'-desoxy-6-azacytidinforbindelser.
DK98063C (da) Fremgangsmåde til fremstilling af 2-chlor-10-(3'-dimethylamino-propyl)-phenthiazin.
DK98062C (da) Fremgangsmåde til fremstilling af 2-chlor-10-(3'-dimethylamino-propyl)-phenthiazin.
DK101740C (da) Fremgangsmåde til fremstilling af N-benzensulfonyl-N'-cycloheptylurinstof-derivater.
DK107171C (da) Fremgangsmåde til fremstilling af β-dialkylaminoethoxy-β'-phenylpropiophenoner.